<?xml version="1.0" encoding="UTF-8"?>
<rss version="2.0"
	xmlns:content="http://purl.org/rss/1.0/modules/content/"
	xmlns:wfw="http://wellformedweb.org/CommentAPI/"
	xmlns:dc="http://purl.org/dc/elements/1.1/"
	xmlns:atom="http://www.w3.org/2005/Atom"
	xmlns:sy="http://purl.org/rss/1.0/modules/syndication/"
	xmlns:slash="http://purl.org/rss/1.0/modules/slash/"
	>

<channel>
	<title>DrugWatch.com</title>
	<atom:link href="http://www.drugwatch.com/feed/" rel="self" type="application/rss+xml" />
	<link>http://www.drugwatch.com</link>
	<description></description>
	<lastBuildDate>Tue, 15 May 2012 14:56:14 +0000</lastBuildDate>
	<language>en</language>
	<sy:updatePeriod>hourly</sy:updatePeriod>
	<sy:updateFrequency>1</sy:updateFrequency>
	<generator>http://wordpress.org/?v=3.3.2</generator>
<xhtml:meta xmlns:xhtml="http://www.w3.org/1999/xhtml" name="robots" content="noindex" />
		<item>
		<title>DePuy Blames BMJ for Overstating Hip Replacement Dangers</title>
		<link>http://www.drugwatch.com/depuy-blames-bmj-for-overstating-dangers.php</link>
		<comments>http://www.drugwatch.com/depuy-blames-bmj-for-overstating-dangers.php#comments</comments>
		<pubDate>Mon, 14 May 2012 13:25:49 +0000</pubDate>
		<dc:creator>Linda Grayling</dc:creator>
				<category><![CDATA[DePuy News]]></category>

		<guid isPermaLink="false">http://www.drugwatch.com/?p=5989</guid>
		<description><![CDATA[Johnson &#038; Johnson shifted attention from victims in order to blame publications like the British Medical Journal for allegedly <a href="http://www.drugwatch.com/depuy-blames-bmj-for-overstating-dangers.php">overstating the dangers</a> of the DePuy ASR and Pinnacle hip replacement. The company says the publication used alarmist language, while critics argue that the facts attest to the <a href="http://www.drugwatch.com/depuy-hip/contamination.php">clear dangers</a> of DePuy’s hip replacements. ]]></description>
		<wfw:commentRss>http://www.drugwatch.com/depuy-blames-bmj-for-overstating-dangers.php/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Lack of Clinical Trial Reporting Puts Consumer Safety At Risk</title>
		<link>http://www.drugwatch.com/clinical-trials-come-into-question.php</link>
		<comments>http://www.drugwatch.com/clinical-trials-come-into-question.php#comments</comments>
		<pubDate>Fri, 11 May 2012 15:02:06 +0000</pubDate>
		<dc:creator>Barb Stephens</dc:creator>
				<category><![CDATA[Latest Drug News]]></category>

		<guid isPermaLink="false">http://www.drugwatch.com/?p=5890</guid>
		<description><![CDATA[The reliability of clinical trials is being questioned after critics discovered loopholes in the system. Drug manufacturers, like <a href="http://www.drugwatch.com/actos/side-effects.php">Actos</a> maker Takeda Pharmaceuticals, may have avoided rules of reporting clinical trial results. The Journal of the American Medical Association stated that <a href="http://www.drugwatch.com/clinical-trials-come-into-question.php">reporting requirements</a> lack enforcement and leaves the public blind to study results.]]></description>
		<wfw:commentRss>http://www.drugwatch.com/clinical-trials-come-into-question.php/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Transvaginal Mesh Lawsuits Expected To Increase</title>
		<link>http://www.drugwatch.com/increase-in-canadian-transvaginal-mesh-lawsuits-expected.php</link>
		<comments>http://www.drugwatch.com/increase-in-canadian-transvaginal-mesh-lawsuits-expected.php#comments</comments>
		<pubDate>Fri, 11 May 2012 12:30:52 +0000</pubDate>
		<dc:creator>Barb Stephens</dc:creator>
				<category><![CDATA[Tranvaginal Mesh News]]></category>

		<guid isPermaLink="false">http://www.drugwatch.com/?p=5699</guid>
		<description><![CDATA[The pain and suffering from transvaginal mesh products have become too much for many Canadian women who received the defective device. Canadian television is <a href="http://www.drugwatch.com/increase-in-canadian-transvaginal-mesh-lawsuits-expected.php">reporting</a> that more women are coming forward to learn more about their legal options, after hearing about the class-action lawsuit filed against Johnson &#038; Johnson, a <a href="http://www.drugwatch.com/transvaginal-mesh/">transvaginal mesh</a> maker. ]]></description>
		<wfw:commentRss>http://www.drugwatch.com/increase-in-canadian-transvaginal-mesh-lawsuits-expected.php/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Hip Replacement Crisis in Europe Causes Demand for Medical Device Registry</title>
		<link>http://www.drugwatch.com/europe-hip-replacement-crisis-demands-registry.php</link>
		<comments>http://www.drugwatch.com/europe-hip-replacement-crisis-demands-registry.php#comments</comments>
		<pubDate>Thu, 10 May 2012 12:57:47 +0000</pubDate>
		<dc:creator>Linda Grayling</dc:creator>
				<category><![CDATA[Metal On Metal Hip News]]></category>

		<guid isPermaLink="false">http://www.drugwatch.com/?p=5816</guid>
		<description><![CDATA[European health officials want a medical device registry to help the U.K. Medicines and Healthcare products Regulatory Agency (MHRA) track metal-on-metal hip replacements. After a study found that almost half of hip replacements require <a href="http://www.drugwatch.com/keep-implant-after-revision-surgery.php">revision surgery</a>, officials believe that a <a href="http://www.drugwatch.com/europe-hip-replacement-crisis-demands-registry.php">registry</a> will better measure the safety of medical devices in the long-term.]]></description>
		<wfw:commentRss>http://www.drugwatch.com/europe-hip-replacement-crisis-demands-registry.php/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Joining Actos Lawsuit MDL Made Easier By Federal Judge</title>
		<link>http://www.drugwatch.com/judge-makes-suing-takeda-easier.php</link>
		<comments>http://www.drugwatch.com/judge-makes-suing-takeda-easier.php#comments</comments>
		<pubDate>Wed, 09 May 2012 11:07:25 +0000</pubDate>
		<dc:creator>Barb Stephens</dc:creator>
				<category><![CDATA[Actos News]]></category>

		<guid isPermaLink="false">http://www.drugwatch.com/?p=5823</guid>
		<description><![CDATA[Patients who have taken the diabetes drug Actos, made by Takeda Pharmaceuticals, now have an <a href="http://www.drugwatch.com/judge-makes-suing-takeda-easier.php">easier process</a> into the Actos MDL. Judge Rebecca Doherty has signed a direct-filing order allowing patients to join instead of filing at local courts, waiting to be transferred The MDL has now <a href="http://www.drugwatch.com/actos-bladder-cancer-lawsuits-spike-in-april.php">grown</a> to include hundreds of cases.]]></description>
		<wfw:commentRss>http://www.drugwatch.com/judge-makes-suing-takeda-easier.php/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Suspicious Link Between Actos and Doctor Raises Safety Concerns</title>
		<link>http://www.drugwatch.com/suspicious-link-between-actos-and-doctor.php</link>
		<comments>http://www.drugwatch.com/suspicious-link-between-actos-and-doctor.php#comments</comments>
		<pubDate>Tue, 08 May 2012 16:30:16 +0000</pubDate>
		<dc:creator>Barb Stephens</dc:creator>
				<category><![CDATA[Actos News]]></category>

		<guid isPermaLink="false">http://www.drugwatch.com/?p=5736</guid>
		<description><![CDATA[Critics of the pharmaceutical industry have found a new target, someone who took down the dangerous diabetes drug Avandia. <a href="http://www.drugwatch.com/suspicious-link-between-actos-and-doctor.php">Dr. Steven Nissen</a> contributed to the research that discovered Avandia’s dangers, but it has been recently been discovered that he has received payments from <a href="http://www.drugwatch.com/whistleblower-says-takeda-underreported-cancer-cases.php">Takeda</a>, the maker of Actos, for contributing to the drug’s promotion. ]]></description>
		<wfw:commentRss>http://www.drugwatch.com/suspicious-link-between-actos-and-doctor.php/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Transvaginal Mesh Lawsuit MDL Receives First Trial Date</title>
		<link>http://www.drugwatch.com/first-transvaginal-mesh-mdl-receives-trial-date.php</link>
		<comments>http://www.drugwatch.com/first-transvaginal-mesh-mdl-receives-trial-date.php#comments</comments>
		<pubDate>Tue, 08 May 2012 12:30:56 +0000</pubDate>
		<dc:creator>Linda Grayling</dc:creator>
				<category><![CDATA[Tranvaginal Mesh News]]></category>

		<guid isPermaLink="false">http://www.drugwatch.com/?p=5740</guid>
		<description><![CDATA[The date for the federal multidistrict litigation cases against transvaginal mesh implant manufacturers are <a href="http://www.drugwatch.com/first-transvaginal-mesh-mdl-receives-trial-date.php">set to begin</a> February 5, 2013. Women who suffered <a href="http://www.drugwatch.com/transvaginal-mesh/">painful side effects</a>, such as erosion, extrusion and dysfunction, will be able to seek justice against the device makers who sold defective products, through the collective federal trial.]]></description>
		<wfw:commentRss>http://www.drugwatch.com/first-transvaginal-mesh-mdl-receives-trial-date.php/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Judge Extends Yaz Lawsuit Deadlines to Allow More Settlements</title>
		<link>http://www.drugwatch.com/judge-allows-for-more-yaz-settlements.php</link>
		<comments>http://www.drugwatch.com/judge-allows-for-more-yaz-settlements.php#comments</comments>
		<pubDate>Mon, 07 May 2012 17:00:14 +0000</pubDate>
		<dc:creator>Barb Stephens</dc:creator>
				<category><![CDATA[Yaz News]]></category>

		<guid isPermaLink="false">http://www.drugwatch.com/?p=5777</guid>
		<description><![CDATA[With an estimated 11,000 lawsuits remaining against Bayer, the maker of the birth control drug Yaz, the company has <a href="http://www.drugwatch.com/bayer-settlements-in-yaz-claims-could-exceed-2-6-billion.php">settled</a> approximately 651 cases and will pay out $142 million. Judge David Herndon has agreed to <a href="http://www.drugwatch.com/judge-allows-for-more-yaz-settlements.php">postpone</a> lawsuit deadlines allowing plaintiffs and Bayer to continue settling cases, avoiding them from going to trial. ]]></description>
		<wfw:commentRss>http://www.drugwatch.com/judge-allows-for-more-yaz-settlements.php/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>DePuy Hip Replacement Lawsuits Filed Reaches 6000</title>
		<link>http://www.drugwatch.com/judges-update-on-depuy-hip-case.php</link>
		<comments>http://www.drugwatch.com/judges-update-on-depuy-hip-case.php#comments</comments>
		<pubDate>Mon, 07 May 2012 12:12:12 +0000</pubDate>
		<dc:creator>Linda Grayling</dc:creator>
				<category><![CDATA[DePuy News]]></category>

		<guid isPermaLink="false">http://www.drugwatch.com/?p=5780</guid>
		<description><![CDATA[Hip replacement patients who received DePuy’s defective ASR hip have filed lawsuits reaching the thousands, according to the judge’s May 1 update. Judge David Katz <a href="http://www.drugwatch.com/judges-update-on-depuy-hip-case.php">announced</a> that a total of 6,000 federal and state lawsuits have <a href="http://www.drugwatch.com/december-will-mark-beginning-of-depuy-asr-cases.php">been filed</a>against the device manufacturer after countless hazards and injuries were attributed to the device.]]></description>
		<wfw:commentRss>http://www.drugwatch.com/judges-update-on-depuy-hip-case.php/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>‘New York Times’ Critical of FDA’s Ties to Medical Device Makers</title>
		<link>http://www.drugwatch.com/new-york-times-criticizes-fda.php</link>
		<comments>http://www.drugwatch.com/new-york-times-criticizes-fda.php#comments</comments>
		<pubDate>Wed, 02 May 2012 05:01:29 +0000</pubDate>
		<dc:creator>Linda Grayling</dc:creator>
				<category><![CDATA[Latest Drug News]]></category>

		<guid isPermaLink="false">http://www.drugwatch.com/?p=5703</guid>
		<description><![CDATA[The Food and Drug Administration, the agency responsible for allowing countless dangerous drugs like Actos or defective medical devices like <a href="http://www.drugwatch.com/transvaginal-mesh/">transvaginal mesh</a> products to hit the market, has faced criticism for a long time. Beyond Congress and device makers pressuring the FDA, the New York Times has now joined this list to become extremely <a href="http://www.drugwatch.com/new-york-times-criticizes-fda.php">critical</a> of the agency.]]></description>
		<wfw:commentRss>http://www.drugwatch.com/new-york-times-criticizes-fda.php/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
	</channel>
</rss>

